THORATEC CORP Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2014 12 months to Jan 3, 2015	FY2013 12 months to Dec 28, 2013	FY2012 12 months to Dec 29, 2012	FY2011 12 months to Dec 31, 2011	FY2010 12 months to Jan 1, 2011
Cash flows from operating activities:
Net Income
Add back: loss from discontinued operations
Net income from continuing operations
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Investment premium amortization (net)
Impairment of intangible assets
Fixed assets write-down
Investment premium amortization, net
Allowance (benefit) for bad debt
Loss on extinguishment of senior subordinated convertible notes
Non-cash interest income and other
Change in fair value of contingent consideration
Non-cash interest expense
Foreign currency re-measurement and other
Tax benefit (expense) related to stock plans
Share-based compensation expense
Excess tax (benefits) expense from share based compensation
Loss on disposal of assets
Change in deferred taxes, net
Write-down on investment
Tax benefit related to stock options

Changes in assets and liabilities (net of acquisition of business):
Receivables
Inventories
Other current and non-current assets
Accounts payable
Income taxes, net
Other current and non-current liabilities
Operating cash flows provided by continuing operations
Operating cash flows used in discontinued operations
Cash provided by operating activities

Cash flows from investing activities:
Purchases of available-for-sale investments
Sales and maturities of available-for-sale investments
Acquisition of a business, net of cash acquired
Purchases of property, plant and equipment
Purchases of non-marketable equity investments
Cash used in investing activities
Loan collections
Purchases of intangibles
Net investing cash flows provided by discontinued operations
Net investing cash flows provided by (used in) continuing operations

Cash flows from financing activities:
Proceeds from stock option exercises
Proceeds from stock issued under employee stock purchase plan
Excess tax benefits (expense) from share based compensation
Repurchase and retirement of common shares
Contingent consideration payment
Redemption of senior subordinated convertible notes
Cash used in financing activities
Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of fiscal year
Cash and cash equivalents at end of fiscal year
Supplemental disclosure of consolidated cash flow information:
Cash paid for income taxes
Cash paid for interest
Supplemental disclosure of consolidated non-cash investing and financing activities:
Extinguishment of senior subordinated convertible notes with issuance of common stock
Transfers of equipment from inventory
Purchases of property, plant and equipment through accounts payable and other accrued liabilities
Repurchases and retirement of common shares through other accrued liabilities

Acquisitions of DuraHeart II (2013) and Levitronix Medical (2011)
Contingent consideration included in other accrued liabilities
Contingent consideration included in contingent liabilities, non-current portion

Net cash (used in) provided by continuing operations
Net cash provided by discontinued operations

Comments